Felipe
Prosper Cardoso
Consultor Médico
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (5)
2024
-
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152
2022
-
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells
Leukemia, Vol. 36, Núm. 8, pp. 1969-1979
2017
-
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Cell Reports, Vol. 19, Núm. 1, pp. 218-224
2016
-
Targeting vasculogenesis to prevent progression in multiple myeloma
Leukemia, Vol. 30, Núm. 5, pp. 1103-1115
2010
-
Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma
Clinical Cancer Research, Vol. 16, Núm. 12, pp. 3260-3269